20 results
8-K
EX-99.1
NRIX
Nurix Therapeutics Inc
8 Jan 24
Regulation FD Disclosure
7:03am
product into the ongoing Phase 1 clinical trial
Strong Financial Position $329M includes funds as of August 31, 2023, and $60M from Pfizer deal R&D collaboration
8-K
EX-99.1
qn0sxf
7 Jul 22
Nurix Therapeutics Reports Fiscal Second Quarter 2022 Financial Results and Provides a Corporate Update
4:09pm
8-K
EX-99.2
2nvnnd2a2s8770sb9
26 May 22
Other Events
7:02am
8-K
26jvp2yqpbs
26 May 22
Other Events
7:02am
8-K
EX-99.1
hqnkj6
26 May 22
Other Events
7:02am
8-K
EX-99.1
72zgiez8ltceexsgr6
10 Jan 22
Other Events
7:11am
10-K
w8x7t
16 Feb 21
Annual report
4:11pm
10-Q
qgpcq0z9
14 Oct 20
Quarterly report
4:02pm
S-1
EX-10.9
dbmufhw5e8 9e
2 Jul 20
IPO registration
4:04pm
DRS
EX-10.9
ivasa
5 May 20
Draft registration statement
12:00am
- Prev
- 1
- Next